Pesquisar | ValuTok

Ksh Dbmr adicionou um novo artigo Networking
2026-03-18 09:13:24

What Pandemic Preparedness Trends Are Driving the Antiviral Drugs Market?
Executive Summary Antiviral Drugs Market Market: Size, Share, and Forecast CAGR Value The global antiviral drugs market size was valued at USD 78.12 billion in 2024 and is expected to reach USD 119.78 billion by 2032, at a CAGR of 5.5% during the forecast period The report has provided crucial information about the elements that are impacting and driving the sales of the Antiviral Drugs...

0 Comentários 0 Compartilhamentos 340 Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
Ksh Dbmr adicionou um novo artigo Networking
2026-03-18 09:13:48

What Pandemic Preparedness Trends Are Driving the Antiviral Drugs Market?
Executive Summary Antiviral Drugs Market Market: Size, Share, and Forecast CAGR Value The global antiviral drugs market size was valued at USD 78.12 billion in 2024 and is expected to reach USD 119.78 billion by 2032, at a CAGR of 5.5% during the forecast period The report has provided crucial information about the elements that are impacting and driving the sales of the Antiviral Drugs...

0 Comentários 0 Compartilhamentos 331 Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
Ksh Dbmr adicionou um novo artigo Networking
2026-03-06 06:55:35

Global Healthcare Preparedness Driving the Infectious Diseases Market
Comprehensive Outlook on Executive Summary Infectious Diseases Market Size and Share CAGR Value The global infectious diseases market size was valued at USD 21.70 billion in 2024 and is expected to reach USD 33.99 billion by 2032, at a CAGR of 5.77% during the forecast period The Infectious Diseases report includes a range of inhibitors as well as driving forces of the market which...

0 Comentários 0 Compartilhamentos 816 Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
Vanshika Swami adicionou um novo artigo Health
2026-02-27 07:35:00

Market Outlook Report: Hepatitis B Therapeutics Demand, Forecast & Opportunities
Hepatitis B therapeutics are medical treatments used to suppress the hepatitis B virus and protect liver cells. They are critical in preventing disease progression. Regular follow-up is important. Hepatitis B Therapeutics Market Overview The Hepatitis B Therapeutics Market is projected to reach US$ 7.26 billion by 2031, growing at a CAGR of 8.8% during the forecast period from 2025 to...

0 Comentários 1 Compartilhamentos 904 Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
KUMUD SINGH adicionou um novo artigo Health
2026-03-30 10:22:44

RdRp Inhibitor Market to Reach USD 521.68 Million by 2028 | CAGR 8.2%
According to a newly published market research report by 24LifeSciences, global RdRp inhibitor market was valued at USD 352.14 million in 2023 and is projected to reach USD 521.68 million by 2028, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2024-2028. RNA-dependent RNA polymerase (RdRp) inhibitors represent a critical antiviral therapy class that prevents...

0 Comentários 0 Compartilhamentos 127 Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!